Thomas Duensing, Ph.D.

Chief Technology Officer

Tom has more than 17 years of experience in scientific research, drug discovery and product development in the area of assay, applications and reagent systems. Tom was Senior Director of In Vitro Pharmacology at Tanox, where he built a successful assay development and high throughput screening program which contributed to the advancement of therapeutic monoclonal antibody candidates into clinical development. Prior to Tanox, Tom was Director of Assay Development at Cellomics and has also held research scientist positions at the National Institutes of Health’s Rocky Mountain Labs and Syntex.

Steve Davenport

Vice President, EMEA Sales

Steve has more than 20 years sales and management experience in the life sciences industry.  Prior to joining IntelliCyt Steve was Vice President European Sales at ProteinSimple, where he oversaw growth of the European sales business from $3.5m to over $10m in 2 years.  Before this Steve was Vice President European Operations at Molecular Devices Corporation, now part of the Medical Technologies division of Danaher Corporation, where he was responsible for the Sales, Support and Service functions throughout Europe and oversaw business growth from $23 to $65m.  Steve was involved in the integration of several acquisitions by Molecular Devices and was also heavily involved in the sale of Molecular Devices to MDS Inc. and subsequently Danaher Corporation.  Steve also spent 13 years at Amersham International, now part of GE Healthcare where he performed multiple sales and business development roles including the market introduction of innovative technologies for Genomics, Proteomics and High Throughput Drug Screening.  Steve holds a BS in Applied Chemistry from the University of Wales Institute of Science and Technology.

Want to learn more or request a demo?

Click Here